Cargando…
SAT-745 Lower Serum Estradiol Levels in Assigned Female at Birth Transgender People with Initiation of Testosterone Therapy: Results from the European Network for the Investigation of Gender Incongruence (ENIGI)
Introduction: Aromatization of exogenous testosterone might result in increased estradiol levels. Concerns have been raised about undesired estrogenic effects in assigned female at birth (AFAB) transgender people. How serum estradiol levels change after initiation of testosterone therapy and if thes...
Autores principales: | , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7207286/ http://dx.doi.org/10.1210/jendso/bvaa046.1276 |
_version_ | 1783530569652502528 |
---|---|
author | Defreyne, Justine Aers, Xavier-Philippe Collet, Sarah M Wiepjes, Chantal Fisher, Alessandra Daphne Schreiner, Thomas Martin, Den Heijer T’Sjoen, Guy G |
author_facet | Defreyne, Justine Aers, Xavier-Philippe Collet, Sarah M Wiepjes, Chantal Fisher, Alessandra Daphne Schreiner, Thomas Martin, Den Heijer T’Sjoen, Guy G |
author_sort | Defreyne, Justine |
collection | PubMed |
description | Introduction: Aromatization of exogenous testosterone might result in increased estradiol levels. Concerns have been raised about undesired estrogenic effects in assigned female at birth (AFAB) transgender people. How serum estradiol levels change after initiation of testosterone therapy and if these levels should be monitored, remains unclear. Methods: This prospective cohort study was part of the European Network for the Investigation of Gender Incongruence (ENIGI). Serum levels of sex steroids were assessed in 746 AFAB transgender people during a three-year follow-up period, starting at the initiation of hormone treatment. Results: Estradiol levels decreased from median [P25-P75] 45.5[24.0-102.2]pg/mL to 36.5[25.0-46.2]pg/mL over three years (P<0.001), a change was already noticeable during the first three months (mean - 17.1 pg/mL, 95% CI -23.8 - -10.6, P<0.001). Serum estradiol levels were lower in people without endogenous estradiol production (contraceptive users or post gonadectomy) at baseline and after three months, compared to people with endogenous estradiol production. Using long acting testosterone undecanoate injections resulted in a more prominent decrease in serum estradiol values over twelve months, compared to short acting mixed testosterone esters (P<0.001) or testosterone gel (P=0.001). Changes in serum estradiol were positively correlated to changes in LH (ρ = 0.107, P<0.001) and negatively correlated to changes in FSH levels (ρ=-0.167, P<0.001) and body mass index (ρ=-0.082, P<0.001). Conclusion: Testosterone administration in AFAB transgender people results in decreasing serum estradiol levels. Although an underlying mechanism for the observed decrease in serum estradiol levels remains difficult to fathom, our results suggest that testosterone administration suppresses endogenous estradiol production. The exception found in people without endogenous estradiol production may be attributed to aromatization of exogenous testosterone. |
format | Online Article Text |
id | pubmed-7207286 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | Oxford University Press |
record_format | MEDLINE/PubMed |
spelling | pubmed-72072862020-05-12 SAT-745 Lower Serum Estradiol Levels in Assigned Female at Birth Transgender People with Initiation of Testosterone Therapy: Results from the European Network for the Investigation of Gender Incongruence (ENIGI) Defreyne, Justine Aers, Xavier-Philippe Collet, Sarah M Wiepjes, Chantal Fisher, Alessandra Daphne Schreiner, Thomas Martin, Den Heijer T’Sjoen, Guy G J Endocr Soc Steroid Hormones and Receptors Introduction: Aromatization of exogenous testosterone might result in increased estradiol levels. Concerns have been raised about undesired estrogenic effects in assigned female at birth (AFAB) transgender people. How serum estradiol levels change after initiation of testosterone therapy and if these levels should be monitored, remains unclear. Methods: This prospective cohort study was part of the European Network for the Investigation of Gender Incongruence (ENIGI). Serum levels of sex steroids were assessed in 746 AFAB transgender people during a three-year follow-up period, starting at the initiation of hormone treatment. Results: Estradiol levels decreased from median [P25-P75] 45.5[24.0-102.2]pg/mL to 36.5[25.0-46.2]pg/mL over three years (P<0.001), a change was already noticeable during the first three months (mean - 17.1 pg/mL, 95% CI -23.8 - -10.6, P<0.001). Serum estradiol levels were lower in people without endogenous estradiol production (contraceptive users or post gonadectomy) at baseline and after three months, compared to people with endogenous estradiol production. Using long acting testosterone undecanoate injections resulted in a more prominent decrease in serum estradiol values over twelve months, compared to short acting mixed testosterone esters (P<0.001) or testosterone gel (P=0.001). Changes in serum estradiol were positively correlated to changes in LH (ρ = 0.107, P<0.001) and negatively correlated to changes in FSH levels (ρ=-0.167, P<0.001) and body mass index (ρ=-0.082, P<0.001). Conclusion: Testosterone administration in AFAB transgender people results in decreasing serum estradiol levels. Although an underlying mechanism for the observed decrease in serum estradiol levels remains difficult to fathom, our results suggest that testosterone administration suppresses endogenous estradiol production. The exception found in people without endogenous estradiol production may be attributed to aromatization of exogenous testosterone. Oxford University Press 2020-05-08 /pmc/articles/PMC7207286/ http://dx.doi.org/10.1210/jendso/bvaa046.1276 Text en © Endocrine Society 2020. http://creativecommons.org/licenses/by-nc-nd/4.0/ This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivs licence (http://creativecommons.org/licenses/by-nc-nd/4.0/), which permits non-commercial reproduction and distribution of the work, in any medium, provided the original work is not altered or transformed in any way, and that the work is properly cited. For commercial re-use, please contact journals.permissions@oup.com |
spellingShingle | Steroid Hormones and Receptors Defreyne, Justine Aers, Xavier-Philippe Collet, Sarah M Wiepjes, Chantal Fisher, Alessandra Daphne Schreiner, Thomas Martin, Den Heijer T’Sjoen, Guy G SAT-745 Lower Serum Estradiol Levels in Assigned Female at Birth Transgender People with Initiation of Testosterone Therapy: Results from the European Network for the Investigation of Gender Incongruence (ENIGI) |
title | SAT-745 Lower Serum Estradiol Levels in Assigned Female at Birth Transgender People with Initiation of Testosterone Therapy: Results from the European Network for the Investigation of Gender Incongruence (ENIGI) |
title_full | SAT-745 Lower Serum Estradiol Levels in Assigned Female at Birth Transgender People with Initiation of Testosterone Therapy: Results from the European Network for the Investigation of Gender Incongruence (ENIGI) |
title_fullStr | SAT-745 Lower Serum Estradiol Levels in Assigned Female at Birth Transgender People with Initiation of Testosterone Therapy: Results from the European Network for the Investigation of Gender Incongruence (ENIGI) |
title_full_unstemmed | SAT-745 Lower Serum Estradiol Levels in Assigned Female at Birth Transgender People with Initiation of Testosterone Therapy: Results from the European Network for the Investigation of Gender Incongruence (ENIGI) |
title_short | SAT-745 Lower Serum Estradiol Levels in Assigned Female at Birth Transgender People with Initiation of Testosterone Therapy: Results from the European Network for the Investigation of Gender Incongruence (ENIGI) |
title_sort | sat-745 lower serum estradiol levels in assigned female at birth transgender people with initiation of testosterone therapy: results from the european network for the investigation of gender incongruence (enigi) |
topic | Steroid Hormones and Receptors |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7207286/ http://dx.doi.org/10.1210/jendso/bvaa046.1276 |
work_keys_str_mv | AT defreynejustine sat745lowerserumestradiollevelsinassignedfemaleatbirthtransgenderpeoplewithinitiationoftestosteronetherapyresultsfromtheeuropeannetworkfortheinvestigationofgenderincongruenceenigi AT aersxavierphilippe sat745lowerserumestradiollevelsinassignedfemaleatbirthtransgenderpeoplewithinitiationoftestosteronetherapyresultsfromtheeuropeannetworkfortheinvestigationofgenderincongruenceenigi AT colletsarahm sat745lowerserumestradiollevelsinassignedfemaleatbirthtransgenderpeoplewithinitiationoftestosteronetherapyresultsfromtheeuropeannetworkfortheinvestigationofgenderincongruenceenigi AT wiepjeschantal sat745lowerserumestradiollevelsinassignedfemaleatbirthtransgenderpeoplewithinitiationoftestosteronetherapyresultsfromtheeuropeannetworkfortheinvestigationofgenderincongruenceenigi AT fisheralessandradaphne sat745lowerserumestradiollevelsinassignedfemaleatbirthtransgenderpeoplewithinitiationoftestosteronetherapyresultsfromtheeuropeannetworkfortheinvestigationofgenderincongruenceenigi AT schreinerthomas sat745lowerserumestradiollevelsinassignedfemaleatbirthtransgenderpeoplewithinitiationoftestosteronetherapyresultsfromtheeuropeannetworkfortheinvestigationofgenderincongruenceenigi AT martindenheijer sat745lowerserumestradiollevelsinassignedfemaleatbirthtransgenderpeoplewithinitiationoftestosteronetherapyresultsfromtheeuropeannetworkfortheinvestigationofgenderincongruenceenigi AT tsjoenguyg sat745lowerserumestradiollevelsinassignedfemaleatbirthtransgenderpeoplewithinitiationoftestosteronetherapyresultsfromtheeuropeannetworkfortheinvestigationofgenderincongruenceenigi |